For SPP1, patients in the high expression subgroup had significantly unfavorable survival in CESC, COAD, GBM, HNSC, LIHC, LUAD, and had marginally significantly unfavorable survival in LUSC and PAAD. The gene discussed is SPP1; the disease is cervical squamous cell carcinoma.